Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHORTCUT: 7 vs 14 Days of Antibiotics for Pyelonephritis in Kidney Transplant
NCT05597540Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute pyelonephritis, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical cure day 30. Started Feb 2024; status: recruiting.
02
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on NCT05597540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597540.